The U.S. Food and Drug Admnistration could authorize COVID-19 antiviral pills from both Pfizer and Merck as soon as this week, Bloomberg reports, "a milestone in the fight against the pandemic that will soon expand therapies for the ill."
According to three individuals with knowledge of the matter, an announcement may arrive as early as Wednesday. Both pills — Pfizer's Paxlovid and Merck's molnupiravir — work as an at-home treatment for higher-risk individuals who have tested positive for COVID-19. Regulators and developers hope the anti-virals will "ease the burden on stretched hospitals with infections poised to soar through the winter in the U.S.," Bloomberg reports. In trials, Pfizer's pill "showed an 89 percent reduction in hospitalization for patients who received the medicine within three days of developing symptoms, compared to patients who got a placebo."
"It's the biggest thing to happen in the pandemic after vaccines," Eric Topol, director of the Scripps Research Translational Institute, told Bloomberg, noting that the unusual, late-in-the-year timing of the announcement indicates the urgency with which the FDA is operating. That said, don't expect the pills to be immediately available everywhere.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The federal government has ordered 10 million courses of Paxlovid and about 3 million courses of molnupiravir, which clinical studies have indicated isn't as effective. Last month, an FDA advisory panel "narrowly recommended" the Merck pill for use, as some members were concerned about its safety in pregnant women. Read more at Bloomberg.
-
The Icelandic women’s strike 50 years onIn The Spotlight The nation is ‘still no paradise’ for women, say campaigners
-
Mall World: why are people dreaming about a shopping centre?Under The Radar Thousands of strangers are dreaming about the same thing and no one sure why
-
Why scientists are attempting nuclear fusionThe Explainer Harnessing the reaction that powers the stars could offer a potentially unlimited source of carbon-free energy, and the race is hotting up
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
